Abstract screen imagery

Issues in Data-monitoring for Complex Clinical Trials

1 minute read

Published: October 19th, 2023

Author: Professor Deborah Ashby Interim Dean of the Faculty of Medicine, Imperial College London

About the lecture 

During a clinical trial, accruing data is often seen in confidence by a data monitoring committee to evaluate whether early termination of the study or other modifications are needed in the light of emerging results. For a classical two-group trial with a single primary endpoint there are well-established statistical approaches. However, more complex trials, such as platform trials or trials with multiple endpoints, present different challenges. Such designs are now being used more regularly, including during the recent COVID-19 pandemic where they rapidly informed clinical practice. We review these designs and current approaches to data-monitoring, as well as challenges that are emerging, and outline where further developments are needed.

Complete the form to download the slides

Related articles

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

Advancing Clinical Trial Design with Bayesian Statistics and Prior Elicitation

April 1st, 2025 1 minute read

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white ...

Unlock the Power of Real-World Evidence in Clinical Research

Unlock the Power of Real-World Evidence in Clinical Research

February 25th, 2025 1 minute read

Discover how Real-World Evidence (RWE) is revolutionizing drug development and clinical decision-making in our latest...

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

A Strategic Approach to Project Optimus: Key Considerations for Oncology Trials

October 10th, 2024 1 minute read

As oncology drug development continues to evolve, the FDA’s Project Optimus is reshaping how clinical trials ap...